David Y Liu Insider Trading $PTGX Protagonist Therapeutics, Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Y Liu.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Y Liu. David Y Liu is Chief Scientific Officer in Protagonist Therapeutics, Inc ($PTGX).
David Y Liu in Protagonist Therapeutics, Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Y Liu: Chief Scientific Officer
Holdings: 62,427 shares
Current Value: $1,117,443
Latest Transaction: Feb 26 2021
$PTGX Market Capitalization: $282.80M
$PTGX Previous Close: $17.90
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David Y Liu in Protagonist Therapeutics, Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2021 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | A | 23.57 | 65,000 | 1,532,050 | 65,000 | |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Grant | A | 0.00 | 10,000 | 0 | 62,427 | 52.4 K to 62.4 K (+19.07 %) |
| Feb 28 2020 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | A | 7.80 | 70,000 | 546,000 | 70,000 | |
| Aug 08 2019 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 8.85 | 3,395 | 30,044 | 49,802 | 53.2 K to 49.8 K (-6.38 %) |
| Mar 04 2019 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | A | 8.02 | 90,000 | 721,800 | 90,000 | |
| Mar 04 2019 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 8.03 | 810 | 6,504 | 51,197 | 52 K to 51.2 K (-1.56 %) |
| Mar 04 2019 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Grant | A | 0.00 | 15,000 | 0 | 52,007 | 37 K to 52 K (+40.53 %) |
| Feb 08 2019 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 7.74 | 3,821 | 29,562 | 37,007 | 40.8 K to 37 K (-9.36 %) |
| Aug 17 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | A | 8.58 | 17,200 | 147,576 | 17,200 | |
| Aug 17 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Grant | A | 0.00 | 25,800 | 0 | 40,828 | 15 K to 40.8 K (+171.68 %) |
| Mar 13 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 4.21 | 3,500 | 14,735 | 35,331 | |
| Mar 13 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 21.29 | 3,500 | 74,500 | 15,028 | 18.5 K to 15 K (-18.89 %) |
| Mar 13 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Buy | M | 4.21 | 3,500 | 14,735 | 18,528 | 15 K to 18.5 K (+23.29 %) |
| Mar 02 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 1.89 | 875 | 1,654 | 9,725 | |
| Mar 02 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | A | 16.95 | 56,500 | 957,675 | 56,500 | |
| Mar 02 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 20.00 | 875 | 17,500 | 13,322 | 14.2 K to 13.3 K (-6.16 %) |
| Mar 02 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Buy | M | 1.89 | 875 | 1,654 | 14,197 | 13.3 K to 14.2 K (+6.57 %) |
| Mar 02 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Grant | A | 0.00 | 9,500 | 0 | 13,322 | 3.8 K to 13.3 K (+248.56 %) |
| Jan 17 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 1.89 | 875 | 1,654 | 10,600 | |
| Jan 17 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 20.00 | 875 | 17,500 | 3,822 | 4.7 K to 3.8 K (-18.63 %) |
| Jan 17 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Buy | M | 1.89 | 875 | 1,654 | 4,697 | 3.8 K to 4.7 K (+22.89 %) |
| Dec 20 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 1.89 | 875 | 1,654 | 11,475 | |
| Dec 20 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 20.00 | 875 | 17,500 | 3,822 | 4.7 K to 3.8 K (-18.63 %) |
| Dec 20 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Buy | M | 1.89 | 875 | 1,654 | 4,697 | 3.8 K to 4.7 K (+22.89 %) |
| Dec 01 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 1.89 | 875 | 1,654 | 12,350 | |
| Dec 01 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 20.00 | 875 | 17,500 | 3,822 | 4.7 K to 3.8 K (-18.63 %) |
| Dec 01 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Grant | A | 1.89 | 875 | 1,654 | 4,697 | 3.8 K to 4.7 K (+22.89 %) |
| Nov 15 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 1.89 | 3,500 | 6,615 | 13,225 | |
| Nov 15 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 4.21 | 3,500 | 14,735 | 38,831 | |
| Nov 15 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 16.97 | 3,500 | 59,381 | 3,822 | 7.3 K to 3.8 K (-47.80 %) |
| Nov 15 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Buy | M | 1.89 | 3,500 | 6,615 | 7,322 | 3.8 K to 7.3 K (+91.58 %) |
| Nov 15 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 16.97 | 3,500 | 59,381 | 3,822 | 7.3 K to 3.8 K (-47.80 %) |
| Nov 15 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Buy | M | 4.21 | 3,500 | 14,735 | 7,322 | 3.8 K to 7.3 K (+91.58 %) |
| Aug 29 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 4.21 | 3,500 | 14,735 | 42,331 | |
| Aug 29 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 15.00 | 3,500 | 52,500 | 2,000 | 5.5 K to 2 K (-63.64 %) |
| Aug 29 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Buy | M | 4.21 | 3,500 | 14,735 | 5,500 | 2 K to 5.5 K (+175.00 %) |
| Jul 12 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 1.89 | 3,500 | 6,615 | 16,725 | |
| Jul 12 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 12.68 | 3,500 | 44,380 | 2,000 | 5.5 K to 2 K (-63.64 %) |
| Jul 12 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Buy | M | 1.89 | 3,500 | 6,615 | 5,500 | 2 K to 5.5 K (+175.00 %) |
| Oct 13 2016 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | A | 21.58 | 65,000 | 1,402,700 | 65,000 |
Page: 1